Endothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarction

Xavier Freixa1, Monica Masotti, Marta Palomo

  • 1Cardiology Department, Hospital Clinic, University of Barcelona, Spain. freixa@clinic.ub.es

Insights

High endothelin-1 (ET-1) levels in ST-elevation myocardial infarction (STEMI) patients predict reduced endothelial progenitor cell (EPC) mobilization. ET-1 offers superior prognostic value compared to circulating endothelial cells (CEC) and EPCs.

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Biology
  • Biomarker Research

Background:

  • Endothelin-1 (ET-1), circulating endothelial cells (CEC), and endothelial progenitor cells (EPC) are key regulators of endothelial function with significant cardiac implications post-myocardial infarction.
  • The interrelationship between ET-1, CEC, and EPCs following ST-elevation myocardial infarction (STEMI) has not been previously investigated.

Purpose of the Study:

  • To investigate the relationship between ET-1, CEC, and EPC concentrations in patients with STEMI.
  • To assess the prognostic value of ET-1, CEC, and EPCs in STEMI patients.

Main Methods:

  • Measurements of ET-1, CEC, and EPC levels were performed in 61 first-time STEMI patients.
  • Blood samples were collected acutely (6-24h) and at 1 week post-admission.
  • Study endpoints included reperfusion outcomes (angiography), left ventricular ejection fraction (echocardiography), and 30-day mortality.

Main Results:

  • Elevated ET-1 plasma levels at admission were associated with lower EPC counts at 1 week (P=0.04).
  • Higher ET-1 concentrations correlated with adverse clinical outcomes, including Killip class ≥2 (P<0.001), suboptimal reperfusion (TIMI flow <3, P=0.002; MBG <3, P=0.004), and increased 30-day mortality (P=0.005).
  • Unlike ET-1, CEC and EPC counts did not show significant associations with these adverse outcomes.

Conclusions:

  • In STEMI patients, elevated ET-1 levels upon admission are predictive of impaired EPC mobilization one week later.
  • ET-1 demonstrates superior prognostic capability for clinical, angiographic, and echocardiographic outcomes in STEMI compared to CEC and EPC concentrations.
Abstract